User profiles for Carolina Argondizo Correia

Carolina Argondizo Correia

Doutoranda, FMUSP
Verified email at usp.br
Cited by 87

[HTML][HTML] Neonatal Immunity to Bordetella pertussis Infection and Current Prevention Strategies

C Argondizo-Correia, AKS Rodrigues… - Journal of immunology …, 2019 - hindawi.com
Bordetella pertussis is the bacterial agent of whooping cough, an infectious disease that is
reemerging despite high vaccine coverage. Newborn children are the most affected, not only …

[HTML][HTML] Humoral and cellular immune responses to CoronaVac up to one year after vaccination

PR Costa, CA Correia, MP Marmorato… - Frontiers in …, 2022 - frontiersin.org
Coronavac is a widely used SARS-CoV-2 inactivated vaccine, but its long-term immune
response assessment is still lacking. We evaluated SARS-CoV-2-specific immune responses, …

Intravenous glutamine administration modulates TNF-α/IL-10 ratio and attenuates NFkB phosphorylation in a protein malnutrition model

ACA Santos, CA Correia, DC de Oliveira… - Inflammation, 2016 - Springer
Protein malnutrition (PM) is a major public health problem in developing countries, affecting
the inflammatory response and increasing susceptibility to opportunistic infections. For this …

[PDF][PDF] Genotype-specific features reduce the susceptibility of South American yellow fever virus strains to vaccine-induced antibodies

…, Y Sun, S Stransky, N Pedreño-Lopez, CA Correia… - Cell host & …, 2022 - cell.com
The resurgence of yellow fever in South America has prompted vaccination against the
etiologic agent, yellow fever virus (YFV). Current vaccines are based on a live-attenuated YF-…

[HTML][HTML] Humoral and cellular immune responses to CoronaVac assessed up to one year after vaccination

PR Costa, CA Correia, MP Marmorato… - medRxiv, 2022 - ncbi.nlm.nih.gov
Background: The Sinovac SARS-CoV-2 inactivated vaccine (CoronaVac) has been
demonstrated to be safe, well tolerated, and efficacious in preventing mild and severe Covid-19. …

Humoral and cellular immune responses to CoronaVac assessed up to one year after vaccination (preprint)

PR Costa, CA Correia, MP Marmorato… - 2022 - pesquisa.bvsalud.org
BackgroundThe Sinovac SARS-CoV-2 inactivated vaccine (CoronaVac) has been
demonstrated to be safe, well tolerated, and efficacious in preventing mild and severe Covid-19. …

Gestational pertussis vaccination and the infant's cellular immune response against whole-cell pertussis vaccine in the first year of life

C Argondizo-Correia… - bioRxiv, 2019 - biorxiv.org
Pertussis resurgence worldwide calls for new prevention strategies, as the recently incorporated
vaccine booster dose during pregnancy, whose aim is to protect newborns from infection…

[HTML][HTML] Experimental design approach in recombinant protein expression: determining medium composition and induction conditions for expression of pneumolysin …

G Marini, MD Luchese, APC Argondizzo… - BMC …, 2014 - Springer
Background Streptococcus pneumoniae (S. pneumoniae) causes several serious diseases
including pneumonia, septicemia and meningitis. The World Health Organization estimates …

Levels of Angiopoietin 2 Are Predictive for Mortality in Patients Infected With Yellow Fever Virus

…, MP Marmorato, CA Correia… - The Journal of …, 2023 - academic.oup.com
In 2018 there was a large yellow fever outbreak in São Paulo, Brazil, with a high fatality rate.
Yellow fever virus can cause, among other symptoms, hemorrhage and disseminated …

Optimization of medium formulation and seed conditions for expression of mature PsaA (pneumococcal surface adhesin A) in Escherichia coli using a sequential …

…, JFMQ Nicolau, APC Argondizzo… - Journal of Industrial …, 2012 - academic.oup.com
… Ana Paula Corrêa Argondizzo , Ana Paula Corrêa Argondizzo … Ana Carolina Andrade de
Góes (Bio-Manguinhos/Fiocruz) for help in purification analysis, and Prof. Dr. Tito Lívio Moitinho …